HENGRUI PHARMA Has Repurchased 585,000 A Shares as of the End of September
Stock News
Yesterday
HENGRUI PHARMA (01276) has issued an announcement that, as of September 30, 2026, the company's current share repurchase plan had accumulated 585,000 A shares bought back through the Shanghai Stock Exchange trading system by way of centralized bidding transactions.
The repurchased shares account for 0.009% of the company's total share capital. The highest purchase price was RMB 45.54 per share, and the lowest was RMB 43.10 per share.
The total amount already paid was RMB 25.8759 million, excluding transaction fees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.